X0508 4 2025-06-11 false 0001597553 Sage Therapeutics, Inc. SAGE 0001188940 COLA MICHAEL F C/O SAGE THERAPEUTICS, INC. 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 true false false false false Stock Option (Right to Buy) 6.77 2025-06-11 4 A false 21500.00 0.00 A 2035-06-11 Common Stock 21500.00 21500.00 D The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan in accordance with Sage's Non-Employee Director Compensation Program. The option will vest in full upon the earlier to occur of June 11, 2026 or the day immediately prior to the 2026 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date. Brandon Marsh, as Attorney-in-Fact for Michael F Cola 2025-06-13